Clinical trial
Early Prospective Therapy Trial to Delay Renal Failure in Children With Alport Syndrome
NCT01485978 is registered in ClinicalTrials.gov with Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Prospective Therapy Trial to Delay Renal Failure in Children With Alport Syndrome
- Lead sponsor
- Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- March 31, 2019
- Enrollment
- 66 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.